Adaptive Biotechnologies ADPT Increase Decrease In Operating Lease Right Of Use Assets And Liabilities
Increase Decrease In Operating Lease Right Of Use Assets And Liabilities at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept adpt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities?
- Adaptive Biotechnologies (ADPT) reported increase decrease in operating lease right of use assets and liabilities of -$2.6M in Q1 2026.
- How has Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities changed year-over-year?
- Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities decreased by 27.8% year-over-year, from -$2.04M to -$2.6M.
- What is the long-term trend for Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities?
- Over 3 years (2022 to 2025), Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities has grown at a 37.2% compound annual growth rate (CAGR), from -$4.05M to -$10.45M.
- What does increase decrease in operating lease right of use assets and liabilities mean?
- This metric captures the net change in operating lease liabilities and the corresponding right-of-use assets during the period. It reflects the cash impact of lease obligations and the non-cash adjustments related to lease accounting standards. Monitoring this helps investors understand the company's underlying lease commitments and their impact on operating cash flow.